Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology – A new chance for causative therapy?

MLA

Achim Goepferich, et al. “Atherosclerosis: Conventional Intake of Cardiovascular Drugs versus Delivery Using Nanotechnology – A New Chance for Causative Therapy?” Journal of Controlled Release, vol. 333, May 2021, pp. 536–59. EBSCOhost, https://doi.org/10.1016/j.jconrel.2021.03.034.

APA

Achim Goepferich, Jonas Groner, & Miriam Breunig. (2021). Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology – A new chance for causative therapy? Journal of Controlled Release, 333, 536–559. https://doi.org/10.1016/j.jconrel.2021.03.034

Chicago

Achim Goepferich, Jonas Groner, and Miriam Breunig. 2021. “Atherosclerosis: Conventional Intake of Cardiovascular Drugs versus Delivery Using Nanotechnology – A New Chance for Causative Therapy?” Journal of Controlled Release 333 (May): 536–59. doi:10.1016/j.jconrel.2021.03.034.